Specialty Generics
Request Sample Report
Specialty Generics Market Size and Growth
The Specialty Generics market is experiencing significant growth, driven by increasing demand for cost-effective therapeutic alternatives. The global market size is projected to reach approximately $300 billion by 2025, reflecting a compound annual growth rate (CAGR) of around 15%. Key factors include rising chronic diseases and expanding healthcare access.
Companies Covered
(Covid 19 Impact Covered)
◍ Teva Pharmaceuticals Industries
◍ Akorn, Inc.
◍ Mylan N.V.
◍ Mallinckrodt
◍ Sandoz International GmbH
◍ Pfizer, Inc.
◍ Sun Pharmaceutical Industries Ltd.
◍ Valeant Pharmaceuticals
◍ Apotex Corp.
◍ Endo International plc.
The Specialty Generics Market features key players like Teva Pharmaceuticals, Mylan, and Sandoz, driving growth through diverse product portfolios and strategic innovations. Companies like Pfizer and Sun Pharma enhance market presence with value-added generics, increasing accessibility. Notable sales figures include Teva ($16 billion) and Mylan ($11 billion).
Request Sample Report
Market Segmentation
By Application
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies
Request Sample Report
By Product
Injectables
Oral
Others
Market Growth
Request Sample Report
$ 3.06 Billion
